Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
148.80    -4.00 (-2.62%)
Bid:
152.60
Ask:
155.40
Spread: 2.80 (1.835%)
Market Cap: £851.60m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Elementis - Pre-close Trading Statement

22 Jun 2016 07:00

ELEMENTIS PLC - Elementis - Pre-close Trading Statement

ELEMENTIS PLC - Elementis - Pre-close Trading Statement

PR Newswire

London, June 21

22 June 2016Elementis plc – pre-close trading updateElementis plc (ELM.L, the "Company" or the "Group"), the Global Specialty Chemicals Company, today issues a trading update ahead of its results for the half year ending 30 June 2016, which will be announced on 2 August 2016.Specialty Products has continued to make progress, in line with the Interim Management Statement issued in April. In coatings, sales of decorative products from the New Martinsville plant continue to make good progress and sales in Asia Pacific have resumed a growth trend, following the destocking and adjustment that took place in the Chinese economy in the second quarter of 2015. Sales in personal care continue to show impressive growth based on new products and geographic expansion. In oilfield, sales have remained relatively stable, following the sharp downturn experienced in the first half of 2015.In Chromium, as previously indicated, sales and contribution margins in North America for the first six months of the year are expected to be similar to the previous year. However, market conditions outside of North America continue to be challenging due to currency weakness against the US dollar, particularly in Eastern Europe. As a result, sales and margins outside of North America for the year as a whole are expected to be materially lower than the previous year. Consequently, earnings per share for the year as a whole is expected to be below the range of market expectations.Strong cash flow generation continues to be a feature of the Group's performance in 2016 and the net cash balance at the end of the year is expected to be ahead of the previous year.

ENDS

Enquiries:

Elementis+ 44 (0) 207 067 2999
Paul Waterman, Chief Executive Brian Taylorson, Finance Director
FTI Consulting
+ 44 (0) 203 727 1000
Deborah Scott
Matthew Cole
Date   Source Headline
16th Jan 20251:45 pmRNSHolding(s) in Company
2nd Jan 202510:06 amRNSTotal Voting Rights
24th Dec 20247:00 amRNSDirectorate Change
9th Dec 20245:05 pmRNSDirector/PDMR Shareholding
2nd Dec 202410:06 amRNSTotal Voting Rights
18th Nov 20247:00 amRNSChief Executive Succession
1st Nov 20249:54 amRNSTotal Voting Rights
29th Oct 20247:00 amRNSThird Quarter Trading Update
11th Oct 202411:18 amRNSDirector/PDMR Shareholding
17th Sep 20248:50 amRNSDirector/PDMR Shareholding
2nd Sep 20249:31 amRNSBlock listing Interim Review
23rd Aug 202410:31 amRNSHolding(s) in Company
14th Aug 202410:53 amRNSAdditional Listing
9th Aug 20242:43 pmRNSHolding(s) in Company
2nd Aug 20245:44 pmRNSHolding(s) in Company
1st Aug 20243:10 pmRNSCorrection of dividend record date
1st Aug 20247:00 amRNSHalf-year Report
15th Jul 202410:59 amRNSHolding(s) in Company
30th May 202412:52 pmRNSDirector/PDMR Shareholding
29th May 20241:07 pmRNSDirector Declaration
8th May 202411:08 amRNSDirector/PDMR Shareholding
3rd May 202411:46 amRNSHolding(s) in Company
1st May 202410:06 amRNSTotal Voting Rights
30th Apr 202411:36 amRNSResult of AGM
30th Apr 20247:00 amRNSFirst quarter trading update
29th Apr 202412:13 pmRNSResponse to open letter from Gatemore
12th Apr 202411:33 amRNSDirector/PDMR Shareholding
12th Apr 202411:28 amRNSDirector/PDMR Shareholding
9th Apr 20246:04 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSAnnual Financial Report & Notice of AGM
19th Mar 20243:02 pmRNSAdditional Listing
15th Mar 20241:00 pmRNSDirectorate Change
12th Mar 20244:38 pmRNSDirector/PDMR Shareholding
12th Mar 20244:33 pmRNSDirector/PDMR Shareholding
8th Mar 20245:56 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirectorate changes
7th Mar 20247:00 amRNSPreliminary results year ended 31 December 2023
1st Mar 20249:30 amRNSBlock listing Interim Review
18th Jan 20247:00 amRNSTrading Update
2nd Jan 20249:45 amRNSTotal Voting Rights
1st Dec 202310:46 amRNSTotal Voting Rights
30th Nov 20239:38 amRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNS2023 Capital Markets Day
1st Nov 20239:46 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSThird Quarter Trading Update
2nd Oct 20239:34 amRNSTotal Voting Rights
20th Sep 202312:09 pmRNSResponse to open letter from Franklin Templeton
12th Sep 20233:13 pmRNSDirector Declaration
8th Sep 20239:30 amRNSHolding(s) in Company
1st Sep 20239:49 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.